Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) EBIT (2016 - 2025)

Historic EBIT for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $208000.0.

  • AtriCure's EBIT rose 10280.89% to $208000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.5 million, marking a year-over-year increase of 2253.35%. This contributed to the annual value of -$40.0 million for FY2024, which is 4995.69% down from last year.
  • Per AtriCure's latest filing, its EBIT stood at $208000.0 for Q3 2025, which was up 10280.89% from -$6.2 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's EBIT ranged from a high of $98.7 million in Q3 2021 and a low of -$15.9 million during Q1 2021
  • For the 5-year period, AtriCure's EBIT averaged around -$3.5 million, with its median value being -$8.1 million (2023).
  • As far as peak fluctuations go, AtriCure's EBIT soared by 257228.76% in 2021, and later plummeted by 11086.76% in 2022.
  • Quarter analysis of 5 years shows AtriCure's EBIT stood at -$12.5 million in 2021, then soared by 66.92% to -$4.1 million in 2022, then crashed by 109.57% to -$8.7 million in 2023, then plummeted by 67.55% to -$14.5 million in 2024, then surged by 101.43% to $208000.0 in 2025.
  • Its EBIT stands at $208000.0 for Q3 2025, versus -$6.2 million for Q2 2025 and -$6.0 million for Q1 2025.